RPT-A A preclinical LINE-1 reverse transcriptase inhibitor candidate developed to suppress aberrant interferon signaling in autoimmune and inflammatory diseases.
Visit productCosigns Received
Be the first Cosign
Put your name behind RPT-A.
Add it to your Products I use list and share why you use it.